Paper62810
Cell-mediated immune response in vitro. II. The mechanism(s) involved in the suppression of the development of cytotoxic lymphocytes.
Hirano T and 1 other. J Immunol, 1976. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. Cell-mediated immune response in vitro. II. The mechanism(s) involved in the suppression of the development of cytotoxic lymphocytes. Papers, record 62810. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/62810
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cell-mediated immune response in vitro. II. The mechanism(s) involved in the suppression of the development of cytotoxic lymphocytes.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Immunity, Cellular | Major topic |
| Immunosuppression Therapy | Major topic |
| Lymphocytes | Major topic |
| Animals | |
| Cytotoxicity Tests, Immunologic | |
| Epitopes | |
| Female | |
| Histocompatibility Antigens | |
| Lymphocyte Culture Test, Mixed | |
| Male | |
| Membranes | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Inbred CBA | |
| Mice, Inbred DBA | |
| Time Factors |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6972991 | Quantitative studies on T cell diversity. II. Determination of the frequencies and Lyt phenotypes of two types of precursor cells for alloreactive cytotoxic T cells in polyclonally and specifically activated splenic T cells. | J Exp Med | 1981 | https://conductscience.org/library/papers/6972991 | PubMed |
| 6461456 | The use of concanavalin A to study the immunoregulation of human T cells. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/6461456 | PubMed |
| 6461453 | Clinical evaluation of B cell and T-regulator cell function using a protein A haemolytic plaque assay. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/6461453 | PubMed |
| 6454647 | Regulation of human cytotoxic lymphocyte responses. II. Suppression by a soluble factor produced by primed lymphocytes. | Immunology | 1981 | https://conductscience.org/library/papers/6454647 | PubMed |
| 6454646 | Regulation of human cytotoxic lymphocyte responses. I. Non-cytolytic suppression mediated by alloantigen-activated cells. | Immunology | 1981 | https://conductscience.org/library/papers/6454646 | PubMed |
| 6221842 | B cell activation by pokeweed mitogen in cultures of normal peripheral blood lymphocytes depleted of T regulator subsets by treatment with OKT4 and OKT8 monoclonal antibodies. | Clin Exp Immunol | 1983 | https://conductscience.org/library/papers/6221842 | PubMed |
| 6169168 | T cell subsets participating in the generation of cytotoxic T cells. | Springer Semin Immunopathol | 1980 | https://conductscience.org/library/papers/6169168 | PubMed |
| 144767 | Regulatory mechanisms in cell-mediated immune responses. VI. Interaction of H-2 and non-H-2 genes in elaboration of mixed leukocyte reaction suppressor factor. | J Exp Med | 1977 | https://conductscience.org/library/papers/144767 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/62810
GET https://conductscience.org/api/papers/v1/62810/authors